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Abstract
Objective: In July 2017 a multidisciplinary clinical Center specialized in rare diseases was 
activated. A rare disease can involve the musculoskeletal system. A multimodality muscu-
loskeletal imaging approach allows for a rapid diagnosis. The purpose of this study was to 
assess when musculoskeletal radiology, ultrasound in particular, plays a primary role in 
the diagnostic path of a rare disease. Methods and materials: The Center included a list of 
621 main rare diseases. Pathologies in which radiology has a primary diagnostic role were 
extracted from the list. From September 2017 to January 2018 all conditions involving the 
musculoskeletal system, including the peripheral nervous system, were systematically evalu-
ated by one radiologist. The second radiologist, an official consultant of the Center, verified 
the list for consistency. Descriptive analysis was performed. Results: A total of 101/621 (16%) 
rare diseases can be diagnosed for the first time in the diagnostic path of the patient with 
medical imaging. A total of 36/101 (36%) rare diseases involve the musculoskeletal system. 
A total of 14/36 (39%) are pediatric diseases, 10/36 (28%) are adult age diseases, while 12/36 
(33%) diseases affect all ages. A total of 23/36 (64%) of the selected rare diseases could be 
diagnosed with MRI, 19/36 (53%) with CT, 23/36 (64%) with X-ray, 9/36 (25%) with an US, 
and 1/36 (3%) with PET. Conclusions: Musculoskeletal imaging could be important for a non-
invasive diagnosis in up to 36/101 (36%) rare diseases, as well as for outcome prediction, 
especially in pediatrics. Musculoskeletal imaging plays a crucial role in the diagnosis of rare 
diseases and could strongly influence the clinical pathway. Ultrasound is crucial in up to 25% 
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Introduction
In July 2017, a clinical Center specialized in rare dis-
eases was funded in our major University Hospital (1). As 
defined by the European Union Regulation on Orphan 
Medicinal Products (1999), in European countries a dis-
ease is defined as rare when it affects fewer than 2000 
people(2). Even if a small number of people are affected 
by a single rare condition, rare diseases are not rare, at 
least in aggregate: there are between 5,000 and 8,000 
rare diseases(3). These pathologies are often serious, 
chronic, with a progressive and worsening course, and 
may be life-threatening. Rare diseases are also known 
as “orphan” diseases because the diagnosis is often very 
difficult or misinterpreted(4). Indeed, the presenting signs 
and symptoms of rare diseases could be very different 
for individual patients and often mimic other patholo-
gies. The diagnosis is often missed or frustratingly slow, 
thereby worsening the patients’ physical and social 
status.
Indeed, it is well known that an early diagnosis of a dis-
ease may improve the prognosis and overall quality of 
life due to timely and appropriate therapies. Diagnostic 
imaging is usually performed and could be the most 
important diagnostic tool for several rare diseases. 
Medical imaging is crucial not only for the diagno-
sis, but also for therapy monitoring and even outcome 
prediction. Recent advances in several medical imag-
ing techniques, such as magnetic resonance imaging 
(MRI), computed tomography (CT) and ultrasound (US), 
guarantee significant improvement in diagnosis due to 
improved sensitivity and tissue characterization. Most 
data provided by diagnostic imaging can also be imme-
diately shared and transmitted by the radiologist to the 
referring physicians(5).
Rare diseases can involve all systems and organs, including 
the musculoskeletal system. Unfortunately, even in highly 
specialized environments with cutting edge resources such 
as genetics, many patients remain undiagnosed despite 
extensive medical evaluation. According to a recent study 
reported in the New England Journal of Medicine, the 
Undiagnosed Diseases Network yielded a rate of diagnosis 
of 35%(6). Therefore, the purpose of the present study was to 
assess when medical imaging plays the primary role in the 
diagnosis of rare musculoskeletal diseases with an empha-
sis on ultrasound. 
Materials and methods
The Center included an alphabetical database of 621 main 
rare diseases (with the main name as well as alternative 
names), based on the available data in the medical litera-
ture, to help patients with orphan diseases find detailed 
information about their conditions(1). 
From September 2017 to January 2018 one junior radiolo-
gist under senior supervision (F.R. and A.T.) evaluated one 
by one all the 621 pathologies from the list to assess when 
radiology had a primary role in the diagnostic pathway. 
PubMed, Cochrane library, Medline (Ovid) and Orphanet 
databases were searched using appropriate keywords and 
following a strict scientific method. Different sources of 
information were compared. Rare diseases involving the 
musculoskeletal system were selected and classified based 
on age groups (adults, children, both adults and children) 
and etiologic sub-types. Further subdivision was made 
according to imaging modalities: magnetic resonance 
imaging (MRI), computerized tomography (CT), ultrasound 
(US), positron emission tomography (PET) and X-ray. The 
analysis was repeated twice to increase accuracy. A second 
senior radiologist (A.T.), official consultant of the Center, 
independently checked the list for consistency. Any dis-
crepancies were resolved through discussion, until con-
sensus was reached. To summarize the basic features of 
the obtained data, descriptive analysis was performed. 
Relevant US findings helpful for clinicians are systemati-
cally reported. 
Results
The first part of the research involved a selection of 
rare diseases that could be diagnosed with an imaging 
approach. Musculoskeletal pathologies were selected and a 
subdivision into categories was performed for each abnor-
mality (Tab. 1).
The role of medical imaging in the diagnosis  
of rare musculoskeletal diseases
A total of 101/621 (16%) rare diseases can be diagnosed for 
the first time with medical imaging. 
A total of 36/101 (36%) rare diseases involve the musculo-
skeletal system, including the peripheral nervous system 
(n = 8/36, 22%).
Rare musculoskeletal conditions according  
to patients’ age and etiopathology
Rare musculoskeletal diseases were subdivided according 
to the age of the affected population: 14/36 (39%) pediat-
ric diseases, 10/36 (28%) adulthood diseases, 12/36 (33%) 
conditions affecting all ages. From the etiopathological 
point of view, the causes vary and are dominated by genetic 
(n = 14/36, 39%) and multifactorial (n = 11/36, 30.5%) fac-
tors. The exact cause of many rare diseases is still unknown 
(n = 11/36, 30.5%). 
Rare musculoskeletal conditions according  
to the imaging technique
A total of 23/36 (64%) of the selected rare diseases could 
be diagnosed with MRI, 19/36 (53%) with CT, 23/36 (64%) 
with X-ray exams, 9/36 (25%) with an US scan, and 1/36 
(3%) with PET.
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Disease name Diagnostic Modality Patients’ age Etiology
1.Achondroplasia prenatal US, X-ray Childhood Genetic (autosomal dominant)(10)
2. Algodystrophy X-rays, CT, MRI All ages Multifactorial
3. Buschke- Ollendorff syndrome CT, X-ray All ages Genetic (autosomal dominant) 
4. Claude Bernard Horner CT, MRI All ages Multifactorial 
5. CREST Syndrome CT, X-ray Adulthood Multifactorial
6. Diffuse cutaneous systemic sclerosis X-ray, CT Adulthood Multifactorial
7. Emery-Dreifuss muscular dystrophy US, MRI Childhood Genetic (autosomal dominant or autosomal recessive or X-linked recessive)(11)
8. Ewing sarcoma X-ray, CT, MRI Childhood Unknown
9. Fibrodysplasia ossificans progressiva X-ray,CT Childhood Genetic (autosomal dominant) 
10. Fibrous dysplasia X-ray, CT Childhood Multifactorial
11. Focal myositis MRI Adulthood Unknown
12. Gorham-Stout syndrome CT, MRI, X-rays All ages Unknown
13. Inclusion body myositis MRI Adulthood Unknown
14. Kienbok disease X-ray, CT, MRI All ages Unknown
15. Klippel-Trenaunay-Weber syndrome X-ray, CT, MRI Childhood Unknown
16. Larsen syndrome X-ray Childhood Genetic (autosomal dominant)
17. Léri-Weill dyschondrosteosis X-ray, CT Childhood Genetic (autosomal dominant)
18. Maffucci syndrome X-ray, CT Childhood Unknown
19. McCune Albright syndrome X-ray Childhood Genetic
20. Meralgia paresthetica MRI, US Adulthood Multifactorial(12)
21. Multifocal motor neuropathy MRI Adulthood Unknown
22. Multiple osteochondromas X-ray, CT Childhood Genetic (autosomal dominant)
23. Nager syndrome X-ray, prenatal US Childhood Genetic(13)
24. Nasu-Hakola disease MRI, X-ray, CT All ages Genetic (autosomal recessive)
25. Neuralgic amyotrophy MRI, US Adulthood Unknown(14,15)
26. Neurofibromatosis type 1 MRI Childhood Genetic (autosomal dominant)
27. Osteogenesis imperfecta MRI, X-ray, CT All ages Genetic  (autosomal dominant or recessive)
28. Osteopetrosis MRI, X-ray, CT All ages Genetic (autosomal dominant or recessive or X-linked recessive)
29. Paget disease MRI Adulthood Unknown 
30. Peripheral neuropathy MRI, US All ages Multifactorial(16)
31.Psuedoachondroplasia X-ray Childhood Genetic (autosomal dominant)
32. Pudendal neuralgia MRI, US Adulthood Multifactorial(17)
33. SAPHO syndrome X-ray, CT, MRI All ages Multifactorial
34. Soft tissue tumor PET, MRI, CT, US All ages Multifactorial(18)
35. Tarlov cysts MRI, CT Adulthood Multifactorial 
36. Tietze syndrome X-ray, MRI, US All ages Unknown(19)
US – ultrasound, MRI – magnetic resonance imaging, CT – computed tomography, PET – positron emission tomography
Tab. 1.  Primary role of medical imaging in the diagnosis: list of selected rare diseases. Diagnostic modality (CT, US, MRI, PET, X-rays), 
patients’ age, etiology of the rare diseases analyzed were considered. The names of rare conditions are indicated in the first column
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Rare musculoskeletal conditions relevant  
to ultrasound
Table 2 presents the main US findings and the role of US 
in nine rare conditions where ultrasonography may have 
an important contribution to diagnosis and even treatment. 
These nine conditions are: achondroplasia, Emery-Dreifuss 
muscular dystrophy, meralgia paresthetica (Fig. 1 A, B), 
Nager syndrome, neuralgic amyotrophy, peripheral neu-
ropathy (Fig. 2), pudendal neuralgia (Fig. 3), soft tissue 
tumor (Fig. 4), and Tietze syndrome. 
Discussion 
A wide range of rare conditions involve the musculoskeletal 
system. Rare musculoskeletal diseases can arise from genetic 
problems in the muscles themselves, like Duchenne muscu-
lar dystrophy, while other involve the nerves (e.g. Charcot-
Marie-Tooth disease) or the bones (e.g. osteogenesis imper-
fecta). The absence of diagnosis represents an unmet medical 
need. Despite innovations in the clinical management of 
more common diseases, up to a quarter of patients diagnosed 
with a rare disease can have a diagnostic delay of between 
5–30 years and 95 % of rare diseases are still without specific 
treatments(5). The diagnosis of a rare musculoskeletal disease 
can be relatively rapid or slow. Some types manifest early in 
life with obvious and severe symptoms, while other emerge 
later. Patients with mild diseases might not notice any symp-
toms until later childhood or adulthood, delaying the diag-
nosis. Even if most rare conditions have congenital causes, 
medical imaging plays an important and primary role in the 
diagnostic pathway. Indeed, although the progress of molecu-
lar genetics has improved, the selection of patients to undergo 
expensive genetic tests is often based on clinical imaging data. 
To the best of our knowledge, an evaluation of the role of radi-
ology in the diagnosis of rare musculoskeletal diseases is miss-
ing in the literature. Groft underlined the growing interest in 
rare diseases with the expanding role and outreach activities 
of patient advocacy groups that have increased public aware-
ness and legislative interest in rare diseases(10). 
In the present paper, we identified several conditions where 
medical imaging generally plays a crucial role in the diag-
nosis. In particular, we identified nine conditions where US 
is crucial. Prenatal ultrasound is crucial to suspect the diag-
nosis before birth in acondorplasia and its variants, early 
onset hydrocephalus, enlarged cerebellum and cisterna 
magna, and hydrancephaly(11). Nager syndrome, acrofacial 
dysostosis and temporomandibular joint disorders could be 
assessed with US as complementary tests(3). In the case of 
Emery-Drayfus sindrome, which is present in the Orphanet 
database, US could be used to assess skeletal muscle and 
soft-tissue disorders, especially at the level of the Achilles ten-
dons(12). US is also helpful in muscular dystrophyes; indeed 
it is the only technique able to show fasciluations. In addi-
tion, ultrasound can identify abnormal echo intensity and 
size. US can be used to evaluate multiple muscles to guide 
not only the electrodiagnostic examination but also muscle 
biopsy if needed. Most muscular dystrophies show increased 
muscle echo intensity due to increased intramuscular fat 
and fibrosis(13). Homogenously increased echogenicity is 
Name of rare diseases according to orphanet database Main US findings and US role Genetic mutation
Achondroplasia and Nager syndorme
Early onset hydrocephalus, enlarged cerebellum 




US identifies muscle fatty infiltration
US assesses Achilles tendon
X (Xq28)
Muscular dystrophy and neuralgic amyotrophy
US identifies muscle fatty infiltration. Homogenously 
increased muscle echo intensity with attenuation of 
the US signal. Inflammatory myopathies can show 
homogenously increased echogenicity. Denervation can 
show „moth-eaten,” atrophic muscles with fasciculation
Various
Meralgia paresthetica Increased caliber of lateral femoral cutaneous nerve.  Useful for infiltrative treatment 
None, it is an entrapment 
syndrome
Peripheral neuropathy and pudendal neuralgia
Increased caliber of the nerve. 
Evaluation of the fascicular texture
Evaluation of extraneural findings






Follow-up of superficial lesions
Depends on tumor  
sub-type
Tietze syndrome
Swelling of the costochondral joints and calcifications
Corticosteroids injection
Unknown
Tab. 2.  Main US findings and the role of US in the nine conditions where US may have an important contribution to diagnosis and even 
treatment
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typical of inflammatory myopathies, but there is lack of sig-
nal attenuation in the first phases of muscular dystrophies. 
In denervation, typical “moth-eaten,” atrophic muscles with 
fasciculations are seen(13). The use of US to assess muscles 
in older and obese patients is limited. In general, muscle 
US yields sensitivities and specificities of 67% to 100% for 
detecting neuromuscular disorders in children(13).
Meralgia paresthetica is the entrapment of the lateral fem-
oral cutaneous nerve at the inguinal ligament. At US, the 
nerve appears hypoechoic and swollen at the inguinal liga-
ment(14). US is helpful not only to confirm the entrapment, 
but is able to identify the underlying cause and guides inter-
ventional therapeutic procedure(14–16). Medical literature is 
full of papers dealing with peripheral nerve ultrasound for 
both diagnosis and treatment(8,17–20). We briefly underline that 
peripheral nerve US is an increasingly popular topic, with 
potential to detect abnormalities of the peripheral nerves 
even with quantitative measurements describing the internal 
fascicular echotexture. US can be also used to introduce the 
use of US as a possible quantitative imaging biomarker(19) 
by calculating quantitative parameters such as fascicular 
ratio or nerve density(19–21). The role of US in patients with a 
soft-tissue mass is related to lump detection, characteriza-
tion, follow-up and biopsy when necessary(22). In the Tietze 
syndrome, an uncommon disease of unknown etiology that 
manifests with pain and tenderness of the parasternal joints, 
US can detect swelling of the costochondral joints, calcifica-
tions and guide corticosteroid injection(23).
Conclusions
In conclusion, medical imaging plays a primary role in the 
diagnosis of musculoskeletal rare diseases and should be 
considered as an important step in the diagnostic pathway. 
The presented data shows that musculoskeletal imaging 
could help diagnose specific rare musculoskeletal diseases, 
including peripheral neuropathies. Incentives for the devel-
opment of preventive and validated diagnostic techniques 
are necessary and strongly recommended. 
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Fig. 1.  A. Short-axis sonogram over the anterior superior iliac spine (ASIS) showing the inguinal ligament (arrowheads) and the normal 
lateral femoral cutaneous nerve (arrow). B. Ultrasound-guided injection around the lateral femoral cutaneous nerve. Arrow: lateral 
femoral cutaneous nerve, arrowheads: needle. With permission from Tagliafico et al.(7)
A B
Fig. 3.  US images of a 35 year-old woman where oblique high-reso-
lution US shows a focal area of enlargement and a hypoecho-
ic area along the course of the pudendal nerve (white arrow) 
at the level of the distal Alcock canal. With permission from 
Tagliafico et al.(8)
Fig. 4.  US images of the typical fat-split sign obtained with 22–2 
MHz ultrasound on a soft-tissues tumor called small intra-
muscular schwannoma (asterisk) revealing a tapered cap of 
hyperechoic fat adjacent to the proximal (1) and distal (2) 
ends of the tumor. With permission from Tagliafico et al.(9)
Fig. 2.  High-resolution US shows enlargement of an hypoechoic 
ulnar nerve (between calipers) in a post-traumatic mononeu-
ropathy at the level of the medial epicondyle
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